Brief: Vitrafy Life Sciences Enters U.S. Cell & Gene Therapy Market With Charter Medical Agreement
02/09/2026 24:55
BRIEF-Vitrafy Life Sciences Enters U.S. Cell & Gene Therapy Market With Charter Medical Agreement Sept 2 (Reuters) - Vitrafy Life Sciences Ltd VFY.AX:
ENTERS U.S. CELL & GENE THERAPY MARKET WITH CHARTER MEDICAL AGREEMENT
Further company coverage: VFY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitrafy Life Sciences
See all newsBrief: Vitrafy Life Sciences Appoints Jan Gielen As CFO
Australia's Vitrafy Life Sciences heads for best day in 2 months on Versiti deal
Australia's Vitrafy Life Sciences gains on entering US market
Brief: Vitrafy Life Sciences Enters U.S. Cell & Gene Therapy Market With Charter Medical Agreement
Brief: Vitrafy Life Sciences Posts FY Operating Loss Of A$14.6 Million